Meet vívoactive 6, the latest health and fitness smartwatch from Garmin
Know your body better with popular fitness, wellness and smart features—all on a bright, colorful display OLATHE, Kan., April 1,...
Pregnancy
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
Updates strengthen Certara’s position as a leader of PBPK modeling in drug development to advance regulatory decision-makingRADNOR, Pa., April 01,...
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in...
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
– Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four...
THE MOM’S CHOICE AWARDS NAMES AI-POWERED PREGNANCY & BABY WELLNESS WEARABLE ‘ELORA’ AMONG THE BEST IN FAMILY-FRIENDLY PRODUCTS
DOVER, Del., March 25, 2025 /PRNewswire/ -- The Mom's Choice Awards® has named Elora*, from leading technology startup LittleOne.Care™, as among...
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
Initial distribution of Emrosi to pharmacies ongoing First prescriptions of Emrosi filled SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) --...
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
Initial distribution of Emrosi to pharmacies ongoing First prescriptions of Emrosi filled SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) --...
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in CanadaLONDON...
Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved,...
Twentyeight Health Hires Former Warby Parker Executive as COO to Support Rapid Growth, Meet Increasing Demand
Mara Castro will lead engineering, product, marketing, and customer experience operations as Twentyeight Health expands essential sexual and reproductive telehealth...
Teladoc Health Expands Connected Care Partnerships
New digital health partners in specialty care, digestive health, fertility, and family building available for Teladoc Health care team referral...
Sidekick Health Expands Women’s Health Portfolio with Launch of MENO! App in a New Clinical Study
NEW YORK, March 10, 2025 /PRNewswire/ -- Sidekick Health, a leading digital health company, today announced the launch of a...
Philips and Ingeborg Initiatives address maternal health challenges in Arkansas with access to critical resources through the Philips Avent Pregnancy+ app
Arkansas moms get access to customized content and information on essential state resources for a healthier pregnancy CAMBRIDGE, Mass. &...
Philips and Ingeborg Initiatives address maternal health challenges in Arkansas with access to critical resources through the Philips Avent Pregnancy+ app
Arkansas moms get access to customized content and information on essential state resources for a healthier pregnancy CAMBRIDGE, Mass. &...
Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also...
PACIFY LAUNCHES NEW, BEST-IN-CLASS MATERNAL HEALTH PLATFORM
Centered on personalizing the patient experience for expecting and new parents, Pacify is revolutionizing virtual care to drive better outcomes...
VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management
VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March...
Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™
ROXYBOND, formulated with patented, first-of-its-kind abuse-deterrent technology SentryBond™, is designed to provide multiple levels of protection PRINCETON, N.J., March 3, 2025...
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C
New website launched in honor of Rare Disease Day, Feb. 28, 2025 Awareness campaign includes educational resources and testing information...
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product...